Characterization of a novel international clonal complex (CC32) of Acinetobacter baumannii with epidemic potential.
Twelve non-replicate Acinetobacter baumannii isolates from five European hospitals, Kuwait, and the US military healthcare system collected between 1980 and 2005 revealed a new clone, CC32. These included representative isolates of outbreaks/cross-infections. Antimicrobial susceptibility and carbapenem-resistant genetic traits varied. The widespread occurrence, the association with an outbreak and the carbapenem resistance indicate that CC32 has epidemic potential.
Center of Pharmaceutical Studies, Faculty of Pharmacy,University of Coimbra,Coimbra,Portugal.
G J
GJ
Da Silva
Department of Infectious Diseases,Leiden University Medical Centre,Leiden,The Netherlands.
T
T
Van Der Reijden
Center of Pharmaceutical Studies, Faculty of Pharmacy,University of Coimbra,Coimbra,Portugal.
S
S
Domingues
Center of Pharmaceutical Studies, Faculty of Pharmacy,University of Coimbra,Coimbra,Portugal.
N
N
Mendonça
US Naval Medical Research Unit No. 6,Peru.
K
K
Petersen
Department of Infectious Diseases,Leiden University Medical Centre,Leiden,The Netherlands.
L
L
Dijkshoorn
D000151:Acinetobacter Infections / Q000453:epidemiology / Q000382:microbiology*; D040981:Acinetobacter baumannii / Q000145:classification* / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D004196:Disease Outbreaks; D024901:Drug Resistance, Multiple, Bacterial; D005060:Europe / Q000453:epidemiology; D006801:Humans; D007730:Kuwait / Q000453:epidemiology; D008889:Military Personnel / Q000706:statistics & numerical data; D014481:United States
D000900:Anti-Bacterial Agents